Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | JAZZ | EXEL | ||
| Company | Acceleron Pharma | Jazz Pharma Plc | Exelixis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.85 | 185.00 | 42.61 | ||
| High | 179.85 | 190.60 | 43.17 | ||
| Low | 177.06 | 184.70 | 42.42 | ||
| Latest | 178.75 | 189.05 | 42.89 | ||
| Change | -0.93 | +5.90 | +0.94 | ||
| % Change | -0.52% | +3.22% | +2.24% | ||
| Volume | 7,884,200 | 936,200 | 1,926,900 | ||
| 20-Day Average Volume | 1,302,050 | 834,545 | 2,754,180 | ||
| Previous Close | 179.68 | 183.15 | 41.95 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 183.83 | 41.68 | ||
| 20-Day Raw Stochastic | 84.01% | 84.73% | 81.79% | ||
| 20-Day Relative Strength | 70.12 | 59.20 | 52.50 | ||
| Weighted Alpha | +57.78 | +70.09 | +15.52 | ||
| Today's Opinion | 100% Buy | 100% Buy | 24% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 8% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | +2.18% since 03/24/26 | +3.18% since 03/24/26 | ||
| Low | 173.17 on 11/16/21 | 181.99 on 03/30/26 | 41.49 on 03/27/26 | ||
| High | 179.94 on 11/17/21 | 191.28 on 03/26/26 | 43.48 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | -0.51% since 02/27/26 | -2.66% since 02/27/26 | ||
| Low | 172.25 on 10/20/21 | 176.67 on 03/06/26 | 39.71 on 03/02/26 | ||
| High | 179.94 on 11/17/21 | 191.54 on 03/02/26 | 43.48 on 03/25/26 | ||
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | +10.89% since 12/26/25 | -7.24% since 12/26/25 | ||
| Low | 120.20 on 08/20/21 | 156.95 on 01/08/26 | 39.71 on 03/02/26 | ||
| High | 189.99 on 09/29/21 | 198.00 on 02/26/26 | 46.31 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | +48.86% since 09/26/25 | +9.86% since 09/26/25 | ||
| Low | 113.49 on 07/15/21 | 125.79 on 09/29/25 | 33.76 on 10/20/25 | ||
| High | 189.99 on 09/29/21 | 198.00 on 02/26/26 | 47.24 on 12/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 11,274,714 | 10,894,794 | ||
| Shares Outstanding, K | 61,156 | 61,560 | 259,709 | ||
| Annual Sales | 92,520,000 | 4,267,590,000 | 2,320,130,000 | ||
| Annual Net Income | -166,030,000 | -356,150,000 | 782,570,000 | ||
| Last Quarter Sales | 34,200,000 | 1,197,930,000 | 598,660,000 | ||
| Last Quarter Net Income | -70,470,000 | 203,450,000 | 244,530,000 | ||
| 60-Month Beta | 0.13 | 0.22 | 0.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | 6.64 on 02/24/26 | 0.94 on 02/10/26 | ||
| Latest Earnings Date | 02/24/22 | 05/05/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 42.68 | 15.21 | ||